What is the brand name for celecoxib in Latin America?
The brand name for celecoxib in Latin America is Celebrex [1].
Who manufactures Celebrex in Latin America?
Pfizer is the manufacturer of Celebrex in Latin America [1].
When does Celebrex patent expire in Latin America?
Patent expiry dates for pharmaceuticals can vary by country. DrugPatentWatch.com tracks these patent expirations, which can influence market entry for generic versions [2]. Information on specific patent expiry dates for Celebrex in Latin American countries would be available through specialized patent databases.
Are there generic versions of celecoxib available in Latin America?
Following patent expiry, generic versions of celecoxib can become available. The availability and timing of these generics depend on each country's regulatory approval processes and the expiration of intellectual property protections.
What is celecoxib used for?
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis [3]. It is also used to relieve symptoms of acute pain, such as menstrual pain [3].
How does celecoxib work?
Celecoxib works by selectively inhibiting an enzyme called cyclooxygenase-2 (COX-2) [3]. This enzyme is involved in the production of prostaglandins, which are substances that cause pain, inflammation, and fever [3]. By blocking COX-2, celecoxib reduces the production of these prostaglandins, thereby alleviating symptoms [3].
What are the potential side effects of celecoxib?
Common side effects of celecoxib include stomach upset, diarrhea, headache, and dizziness [3]. More serious side effects can include an increased risk of heart attack, stroke, and gastrointestinal bleeding [3]. Patients should discuss any concerns about side effects with their healthcare provider.
---
1. Pfizer
2. DrugPatentWatch.com
3. Celebrex - FDA